The Currax Executive Leadership Team are a globally experienced group of senior leaders dedicated to patients, patient access, and driving the growth of our organization.

< Back to Leadership

Aaron Chesnut

VP, Technical Operations

Aaron Chesnut joined Currax Pharmaceuticals LLC in 2021 as the VP, Technical Operations, bringing with him more than 20 years of strategic and operational experience in global biopharmaceutical, medical device, biotech, and clinical research. He has implemented best practices in operations, engineering, quality, validation, clinical trials, manufacturing, laboratory testing, supply chain, and regulatory affairs. In addition, Aaron has managed the successful development, tech transfer, licensure, and operations of numerous drug and biologic products.

Aaron has deep experience in technical operations including serving as Site Head of Quality at Allergan’s Biologic Drug Substance BLI facility for the manufacture of BOTOX®. Additionally, he led the design, build, qualification, and licensure of pharmaceutical manufacturing facilities, including Genentech’s Oceanside Drug Substance/API facility and their Oregon Aseptic Drug Product facility.

Previous to Currax Pharmaceuticals, Aaron was the Owner and Principal Consultant for Foundation Solutions GxP, where he led a team of senior consultants for the startup, tech transfer, and FDA licensure of biosimilar products manufactured at their CMO facility in South Korea. Aaron has served in senior roles at Prolacta Bioscience as Director of Quality Control, as Senior Director of Quality & MSAT at PMI BioPharma Solutions, and served in Senior Engineering roles at BiogenIDEC (acquired by Genentech), and Baxter BioScience.

Prior to entering the pharmaceutical industry, Aaron spent three years with NASA working with a research team that investigated the biologic impact of ionizing radiation to the human body to support deep space travel.

Aaron received his Bachelor of Science in Biochemistry from the University of California.